| |
| Magyar Neuroszonológiai Társaság |
|
| 2025 World Pediatrics Conference |
 Rendezvény kezdete: 2025.10.10. | Rendezvény vége: 2025.10.11. |
| Szakterület(ek): Nukleáris Medicina, Sebészet, Gyermekgyógyászat, Kardiológia, Orvosi informatika, Diabetológia |
| Tudományos információ: Silvia Morris |
| Munkahely neve: Episirus Scientifica |
| Címe: USA, 19803 1521 Concord Pike Ste 301, 246 |
| Tel: +13024401610 |
| E-mail: pediatrics@episirus.org |
| Szervező: Silvia Morris |
| Címe: USA, |
| E-mail: pediatrics@episirus.org |
| Helyszín: Singapore, Singapore, Singapore, Episirus Scientifica |
| A rendezvény Web oldala: https://pediatrics.episirus.org/ |
Episirus Scientifica welcomes you to attend the 2025 World Paediatrics Conference
(2025WPC) which is going to be held during October 10–11, 2025, in Singapore around the
theme ‘Innovating Pediatric Care for a Healthier Future’ accredited with CPD credits which
enable the professionals from worldwide to exchange their views on a wide variety of topics
affecting child care and those suffering from pediatric diseases around the world. Since
Genetic variance, developmental issues and Congenital defects are of a greater concern to
pediatricians, we will be exploring more into these fields. This international meet
(2025WPC) anticipates hundreds of participants including keynote speakers, Oral
presentations by renowned speakers and poster presenters besides delegates around the
world. This conference perhaps a giant event that creates an ideal platform to share
expertise addressing current advancements involved in Pediatric and Neonatal care. It will
be a wonderful opportunity for all the delegates as it provides an international networking
opportunity to collaborate with the world-class Pediatric and Medical Associations.
Few Topics which will be covered:
Pediatric Biochemistry
Pediatric Epilepsy
Pediatric Genetics
Neonatology and Pediatric Intensive Care
Pediatric Infectious Diseases
Pediatric Neuroradiology
Child Nutrition
Pediatric Immunology
Pediatric Allergy and Dermatology
Pediatric Cardiology
Pediatric Psychology and Adolescent Medicine
Pediatric Neurology
Pediatric Hematology and Oncology
Pediatric Emergencies and many more
Target Audience:
Pediatrician
Pediatirc Cardiologists
Pediatric Neurologists
Pediatric Researchers
Pediatric Scientists
Pediatric Nurses
Pediatric Dermatologists
Pediatric Faculty
Medical Colleges
Pediatric Physicians
Training Institutes
Industry professionals
Researchers
Fellows or Postdoctoral Students
Therapists
Emeritus
Young Research Scientists
Business Delegates
Medical Students
Device Manufacturing Companies
Pediatric Associations and Societies
|
|
|
 |
| |
| Családorvos Kutatók Országos Szervezete |
|
| Educational masterclass on diabetes for Primary Care (Frankfurt, December 14-15.) - invitation for physicians from Hungary |
| Rendezvény kezdete: 2019.12.14. | Rendezvény vége: 2019.12.15. |
| Helyszín: Germany, Frankfurt, |
| A rendezvény Web oldala: https://integress.cvent.com/ASCENDMasterclass |
An international CME-accredited educational initiative in diabetes
Why join?
New data from cardiovascular outcomes trials in diabetes have shown that some newer agents have proven CV benefits (e.g. GLP-1 receptor agonists and SGLT2 inhibitors). The compelling evidence has led to significant changes in treatment paradigms as reflected by the new ADA/EASD Consensus Report on the Management of Hyperglycaemia in Type 2 Diabetes.
This highly interactive and skills-based Masterclass will provide an opportunity to discuss the rationale and benefits of new clinical approaches and to share experiences with experts in the field of diabetes management.
Sessions will include:
• Strategies for individualizing therapy
• Applying new diabetes therapies with CV benefit in practice
• Assessing cardiovascular risk
• Obesity as a treatable condition
• Instilling confidence in patients in using injectables
• New formulations on the horizon
How do I join?
The masterclass is free of charge, travel and accommodation will be provided as appropriate.
To submit an application please visit https://integress.cvent.com/ASCENDMasterclass Places are limited.
Invitation
|
|
|
|
| |
| Családorvos Kutatók Országos Szervezete |
|
| Educational masterclass on diabetes for Primary Care (Frankfurt, December 14-15.) - invitation for physicians from Hungary |
| Rendezvény kezdete: 2019.12.14. | Rendezvény vége: 2019.12.15. |
| Helyszín: Germany, Frankfurt, |
| A rendezvény Web oldala: https://integress.cvent.com/ASCENDMasterclass |
An international CME-accredited educational initiative in diabetes
Why join?
New data from cardiovascular outcomes trials in diabetes have shown that some newer agents have proven CV benefits (e.g. GLP-1 receptor agonists and SGLT2 inhibitors). The compelling evidence has led to significant changes in treatment paradigms as reflected by the new ADA/EASD Consensus Report on the Management of Hyperglycaemia in Type 2 Diabetes.
This highly interactive and skills-based Masterclass will provide an opportunity to discuss the rationale and benefits of new clinical approaches and to share experiences with experts in the field of diabetes management.
Sessions will include:
• Strategies for individualizing therapy
• Applying new diabetes therapies with CV benefit in practice
• Assessing cardiovascular risk
• Obesity as a treatable condition
• Instilling confidence in patients in using injectables
• New formulations on the horizon
How do I join?
The masterclass is free of charge, travel and accommodation will be provided as appropriate.
To submit an application please visit https://integress.cvent.com/ASCENDMasterclass Places are limited.
Invitation
|
|
|
|
| |
| Családorvos Kutatók Országos Szervezete |
|
| Educational masterclass on diabetes for Primary Care (Frankfurt, December 14-15.) - invitation for physicians from Hungary |
| Rendezvény kezdete: 2019.12.14. | Rendezvény vége: 2019.12.15. |
| Helyszín: Germany, Frankfurt, |
| A rendezvény Web oldala: https://integress.cvent.com/ASCENDMasterclass |
An international CME-accredited educational initiative in diabetes
Why join?
New data from cardiovascular outcomes trials in diabetes have shown that some newer agents have proven CV benefits (e.g. GLP-1 receptor agonists and SGLT2 inhibitors). The compelling evidence has led to significant changes in treatment paradigms as reflected by the new ADA/EASD Consensus Report on the Management of Hyperglycaemia in Type 2 Diabetes.
This highly interactive and skills-based Masterclass will provide an opportunity to discuss the rationale and benefits of new clinical approaches and to share experiences with experts in the field of diabetes management.
Sessions will include:
• Strategies for individualizing therapy
• Applying new diabetes therapies with CV benefit in practice
• Assessing cardiovascular risk
• Obesity as a treatable condition
• Instilling confidence in patients in using injectables
• New formulations on the horizon
How do I join?
The masterclass is free of charge, travel and accommodation will be provided as appropriate.
To submit an application please visit https://integress.cvent.com/ASCENDMasterclass Places are limited.
Invitation
|
|
|
|
